Search
Close this search box.
Search
Close this search box.

Category: English

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) — Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine

LS Retail and FreedomPay partner to deliver unified payments worldwide

Philadelphia, Pennsylvania, July 15, 2024 (GLOBE NEWSWIRE) — LS Retail, an Aptos Company has partnered with FreedomPay, the world’s largest independent payment gateway. This partnership enables retail and hospitality businesses that use LS Retail software to deliver simpler, faster payment experiences to their customers with minimum effort. LS Retail: Supporting

Minimum Deposit Casinos Announces Completion of Full Website Revamp

Before and After: MDC Website Redesign Comparison of the Minimum Deposit Casinos website before and after the comprehensive redesign. The updated site features streamlined navigation, enhanced functionality, a modern aesthetic, updated logo, and improved user-centric features. WATERFORD, Ireland, July 15, 2024 (GLOBE NEWSWIRE) — Minimum Deposit Casinos (MDC), a premier

Discover Innovation and Rewards at CHINT Limitless 2024 Super Brand Season

CHINT Limitless super brand season SHANGHAI, July 10, 2024 (GLOBE NEWSWIRE) — CHINT is excited to announce the global launch of its “Limitless 2024 Cool Season” campaign, running from June 1st to July 31st, 2024. This exciting campaign aims to honor electricians, installers, and panel builders worldwide, recognizing their invaluable

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment

Call for Nominations: 2024 Global Citizen Award

LONDON, July 02, 2024 (GLOBE NEWSWIRE) — Leading international residence and citizenship advisory firm Henley & Partners, in partnership with Andan Foundation, a Swiss non-profit humanitarian organization, is pleased to announce the call for nominations for the 2024 Global Citizen Award. Created ten years ago in 2014, the Global Citizen